COMPASS Pathways CMPS
NASDAQ CMPS
$9.30 +0.05 (+0.54%)
At close: Nov 11, 2026 · 4:00 PM EST

COMPASS Pathways (CMPS) Other Accumulated Expenses (2019 - 2021)

Updated

COMPASS Pathways (CMPS) recorded Other Accumulated Expenses of $8,000 in Q4 2020, down 87.3% from $63,000 a year earlier.

Analysis

COMPASS Pathways (CMPS) Other Accumulated Expenses (2019 - 2021) Analysis & Trends

  • Across earlier years, Other Accumulated Expenses came in at $63,000 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 COMPASS Pathways 1.31 Bn -182.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 304,000.00
Dec 31, 2020 8,000.00
Sep 30, 2020 13,000.00
Dec 31, 2019 63,000.00
API Access

COMPASS Pathways Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=CMPS&period=max&api_key=YOUR_API_KEY